ABVX

    COM:ABIVAX

    Abivax

    • Stock

    5.75

    −4.49%

    −0.27

    EUR last updated 01/04 01:29:30

    Last Close

    6.02

    31/03 15:35

    Market Cap

    790.24M

    Beta: -

    Volume Today

    40.93K

    Avg: -

    • name

      ABIVAX Société Anonyme
    • homepage url

      www.abivax.com
    • country

      FRFrance
    • linkedin url

      abivax/
    • crunchbase url

      abivax
    • employee count

      61
    • sector

      Healthcare
    • industry

      Biotechnology

    Description

    ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; an...Show More

    peer of

    competitor of